RNA-Based Technologies for Engineering Plant Virus Resistance

被引:36
作者
Taliansky, Michael [1 ,2 ]
Samarskaya, Viktoria [1 ]
Zavriev, Sergey K. [1 ]
Fesenko, Igor [1 ]
Kalinina, Natalia O. [1 ,3 ]
Love, Andrew J. [2 ]
机构
[1] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia
[2] James Hutton Inst, Dundee DD2 5DA, Scotland
[3] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia
来源
PLANTS-BASEL | 2021年 / 10卷 / 01期
关键词
dsRNA; siRNA; miRNA; lncRNA; amiRNA; tasiRNA; RNAi; CRISPR-Cas;
D O I
10.3390/plants10010082
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
In recent years, non-coding RNAs (ncRNAs) have gained unprecedented attention as new and crucial players in the regulation of numerous cellular processes and disease responses. In this review, we describe how diverse ncRNAs, including both small RNAs and long ncRNAs, may be used to engineer resistance against plant viruses. We discuss how double-stranded RNAs and small RNAs, such as artificial microRNAs and trans-acting small interfering RNAs, either produced in transgenic plants or delivered exogenously to non-transgenic plants, may constitute powerful RNA interference (RNAi)-based technology that can be exploited to control plant viruses. Additionally, we describe how RNA guided CRISPR-CAS gene-editing systems have been deployed to inhibit plant virus infections, and we provide a comparative analysis of RNAi approaches and CRISPR-Cas technology. The two main strategies for engineering virus resistance are also discussed, including direct targeting of viral DNA or RNA, or inactivation of plant host susceptibility genes. We also elaborate on the challenges that need to be overcome before such technologies can be broadly exploited for crop protection against viruses.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 50 条
  • [21] The coming of RNA-based pest controls
    Xu Linghua
    Zeng Baosheng
    Noland Jeffery E
    Huang Yongping
    Zhou Xuguo
    植物保护学报, 2015, 42 (05) : 673 - 690
  • [22] RNA-based therapeutics in cardiovascular disease
    Tan Phat Pham
    Kremer, Veerle
    Boon, Reinier A.
    CURRENT OPINION IN CARDIOLOGY, 2020, 35 (03) : 191 - 198
  • [23] RNA-based therapeutics for neurological diseases
    Anthony, Karen
    RNA BIOLOGY, 2022, 19 (01) : 176 - 190
  • [24] Progress and prospects: RNA-based therapies for treatment of HIV infection
    Scherer, L.
    Rossi, J. J.
    Weinberg, M. S.
    GENE THERAPY, 2007, 14 (14) : 1057 - 1064
  • [25] Progress and prospects: RNA-based therapies for treatment of HIV infection
    L Scherer
    J J Rossi
    M S Weinberg
    Gene Therapy, 2007, 14 : 1057 - 1064
  • [26] RNAi and microRNA: breakthrough technologies for the improvement of plant nutritional value and metabolic engineering
    Guiliang Tang
    Gad Galili
    Xun Zhuang
    Metabolomics, 2007, 3 : 357 - 369
  • [27] RNAi and microRNA: breakthrough technologies for the improvement of plant nutritional value and metabolic engineering
    Tang, Guiliang
    Galili, Gad
    Zhuang, Xun
    METABOLOMICS, 2007, 3 (03) : 357 - 369
  • [28] Current RNA-based Therapeutics in Clinical Trials
    Zhou, Ling-Yan
    Qin, Zhou
    Zhu, Yang-Hui
    He, Zhi-Yao
    Xu, Ting
    CURRENT GENE THERAPY, 2019, 19 (03) : 172 - 196
  • [29] Fidelity in RNA-based recognition of transposable elements
    Ugolini, Ilaria
    Halic, Mario
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2018, 373 (1762)
  • [30] Technological development of structural DNA/RNA-based RNAi systems and their applications
    Jeong, Eun Hye
    Kim, Hyejin
    Jang, Bora
    Cho, Hyesoo
    Ryu, Jaehee
    Kim, Boyeon
    Park, Youngkuk
    Kim, Jieun
    Lee, Jong Bum
    Lee, Hyukjin
    ADVANCED DRUG DELIVERY REVIEWS, 2016, 104 : 29 - 43